Trial
NCT00533351
Safety and Efficacy of AGN201781 in Neuropathic Pain
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Allergan
Collaborators
—
Condition
Neuralgia
Intervention
AGN201781
Why stopped
This study was terminated early due to low enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-02-24